Using a mobile app to track blood sugar in pregnant women with diabetes
Effect of a Mobile Application on Blood Sugar Testing Compliance in Pregnant Women With Diabetes
This study is testing if a mobile app can help pregnant women with diabetes keep better track of their blood sugar levels compared to using paper logs.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 40 (estimated) |
| Ages | 18 Years to 100 Years |
| Sex | Female |
| Sponsor | Augusta University Academic / other |
| Locations | 1 site (Augusta, Georgia) |
| Trial ID | NCT06005987 on ClinicalTrials.gov |
What this trial studies
This study evaluates the effectiveness of a mobile app compared to traditional paper logs for monitoring blood sugar levels in pregnant women diagnosed with type 2 diabetes or gestational diabetes. Participants will record their blood sugar values four times daily, and the study aims to assess compliance and the percentage of readings within the target range. Women will be recruited from obstetric clinics at Augusta University, and the OneTouch Reveal application will be utilized for the mobile tracking. The goal is to determine if the app improves adherence to blood sugar monitoring compared to paper logs.
Who should consider this trial
Good fit: Ideal candidates are women aged 18 and older with a verified intrauterine pregnancy of at least 12 weeks and diagnosed with type 2 diabetes or gestational diabetes.
Not a fit: Patients with type 1 diabetes or those using continuous glucose monitors or other mobile applications for tracking blood sugar will not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could enhance blood sugar management and improve health outcomes for pregnant women with diabetes.
How similar studies have performed: Other studies have shown promising results using mobile applications for diabetes management, indicating potential success for this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * 18 years and older * Verified intrauterine pregnancy * At least 12 weeks gestation * Diagnosed with either type 2 diabetes mellitus or gestational diabetes mellitus. Exclusion Criteria: * Patients with less than 4 weeks anticipated to be remaining in pregnancy * Pre-existing use of a continuous glucose monitor or other mobile application for glucose tracking * Type 1 diabetes mellitus * Non-English speaking patients
Where this trial is running
Augusta, Georgia
- Augusta University — Augusta, Georgia, United States (Recruiting)
Study contacts
- Principal investigator: Rebecca Keipper, MD — Augusta University
- Study coordinator: Rebecca Keipper, MD
- Email: rkeipper@augusta.edu
- Phone: 7067212541
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.